Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234000
Status:
TERMINATED
Last Update Posted:
2020-07-31
First Post:
2005-10-05
Brief Title:
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| secondary myelodysplastic syndromes | View |
| refractory anemia with excess blasts in transformation | View |
| refractory anemia with excess blasts | View |
| refractory anemia with ringed sideroblasts | View |
| refractory anemia | View |
| chronic myelomonocytic leukemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |